Land: Australië
Taal: Engels
Bron: Department of Health (Therapeutic Goods Administration)
insulin, Quantity: 100 IU/mL
Eli Lilly Australia Pty Ltd
insulin
Injection, solution
Excipient Ingredients: water for injections; sodium hydroxide; metacresol; hydrochloric acid; glycerol
Subcutaneous
5x3mL
(S4) Prescription Only Medicine
OTHER CONDITIONS: Refrigerate - do not freeze. INDICATIONS: For the treatment of insulin dependent diabetic patients.
Visual Identification: Clear, sterile, colourless solution.; Container Type: Cartridge; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
1992-05-11
HUMULIN ® _CARTRIDGES_ _Biosynthetic Human Insulin (rbe)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about HUMULIN. It does not contain all the available information. It does not take the place of talking with your doctor or pharmacist. The information in this leaflet was last updated on the date shown on the final page. More recent information on this medicine may be available. Make sure you speak to your pharmacist, nurse or doctor to obtain the most up to date information on this medicine. You can also download the most up to date leaflet from www.lilly.com.au. The updated leaflet may contain important information about HUMULIN and its use that you should be aware of. All medicines have risks and benefits. YOUR DOCTOR HAS WEIGHED THE RISKS OF YOU TAKING HUMULIN AGAINST THE BENEFITS THEY EXPECT IT WILL HAVE FOR YOU. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THIS MEDICINE. You may need to read it again. WHAT HUMULIN IS USED FOR HUMULIN is used to reduce high blood sugar (glucose) levels in patients with diabetes mellitus. Diabetes is a condition in which your pancreas does not produce enough insulin to control your blood sugar level. Extra insulin is therefore needed. There are two types of diabetes mellitus: Type 1 diabetes - also called juvenile onset diabetes. Type 2 diabetes - also called maturity onset diabetes. Patients with type 1 diabetes always require insulin to control their blood sugar levels. Some patients with type 2 diabetes may also require insulin after initial treatment with diet, exercise and tablets. HUMULIN is identical to the insulin produced by the pancreas. There are 3 different types of HUMULIN cartridges: • HUMULIN R • HUMULIN NPH • HUMULIN 30/70. Your doctor will tell you the type of HUMULIN that is best suited to you. The duration of action of the insulin you inject will vary according to the type being used, the dose, injection site, blood flow, temperature and Lees het volledige document
AUSTRALIAN PRODUCT INFORMATION vDA5.0_Jan21 SUPERSEDES: vA4.0_Mar20 Page 1 of 10 HUMULIN® R (REGULAR – NEUTRAL – SOLUBLE HUMAN INSULIN (RBE) INJECTION) HUMULIN® NPH (ISOPHANE – NPH – HUMAN INSULIN (RBE) SUSPENSION) HUMULIN® 30/70 (30% REGULAR HUMAN INSULIN (RBE) INJECTION AND 70% ISOPHANE HUMAN INSULIN (RBE) SUSPENSION) 1. NAME OF THE MEDICINE Insulin 2. QUALITATIVE AND QUANTITATIVE COMPOSITION There are three different presentations in the HUMULIN range: HUMULIN R (regular-neutral-soluble) – neutral human insulin of recombinant DNA origin. HUMULIN NPH (isophane) – isophane human insulin of recombinant DNA origin. HUMULIN 30/70 – a mixture consisting of 30% Regular (neutral human insulin of recombinant DNA origin) and 70% NPH (isophane human insulin of recombinant DNA origin. For the full list of excipients, see section 6.1 LIST OF EXCIPIENTS HUMULIN is found to be chemically, physically, biologically and immunologically equivalent to pancreatic human insulin, which differs slightly from porcine or bovine insulin in amino acid composition. 3. PHARMACEUTICAL FORM HUMULIN R: A sterile, clear colourless, aqueous solution of neutral human insulin (rbe) adjusted to pH 6.6 to 8.0. HUMULIN NPH: A sterile suspension of white, crystalline precipitate of isophane human insulin (rbe) in an isotonic phosphate buffer adjusted to pH 6.9 to 7.5 HUMULIN 30/70: A sterile mixture of 30% Regular and 70% NPH human insulin (rbe) adjusted to pH 6.9 to 7.5 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS HUMULIN is indicated for the treatment of insulin-dependent diabetic patients. vA5.0_Jan21 SUPERSEDES: vA4.0_Mar20 Page 2 of 10 4.2 DOSE AND METHOD OF ADMINISTRATION The dosage should be determined by the physician, according to the requirements of the patient. During changes to a patient’s insulin regimen, increase the frequency of glucose monitoring. Subcutaneous administration, preferably by the patient, should be in the upper arms, thighs, buttocks, or abdomen. Use of injection sites should be rotated so that Lees het volledige document